Improving Immunization and Injectable Medicine Access
- Understand the impact of the “Zero-dose Children” crisis on global immunization efforts.
- Analyze the safety concerns associated with injectable medicines across different regions and explore innovative solutions, like prefilled injectors, can combat transmittable diseases.
- Examine the issues of vaccine waste caused by multi-dose vials and identify potential solutions to reduce waste and improve access to essential vaccines.
- Discuss the crucial role of community health workers in bridging the gap between The Last Mile and successful vaccination campaigns.
Reserve a session for your team
What to Expect in this Online Lunch & Learn
This session is designed to provide participants with a comprehensive understanding of the challenges faced in achieving universal access to safe and effective immunization and injectable medicines. The session covers four key learning objectives, including gaining insight into the impact of the "Zero-dose Children" crisis on global immunization efforts, understanding safety concerns associated with injectable medicines across different regions, exploring innovative solutions such as prefilled injectors that can combat transmittable diseases, and identifying the issues of vaccine waste caused by multi-dose vials.
The presentation focuses on potential solutions to reduce waste and improve access to essential vaccines, as well as the crucial role of community health workers in bridging the gap between the last mile and successful vaccination campaigns. Participants will have gained an understanding of the challenges and potential solutions related to improving immunization and injectable medicine access, empowering them to make a positive impact on global health outcomes.
The Prefilled ApiJect Injector* is the combination of two trusted technologies: BFS aseptic drug packaging process, and a pen needle-style needle hub.
Our approach is just one example of how we are creating prefilled injectors that work for everyone in all markets… that are easy to use, cost effective, and more environmentally friendly.
ApiJect has product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
The Future of Drug Delivery: Market Access and Expansion
- Understand the impact of the “Zero-dose Children” crisis on global immunization efforts.
- Analyze the safety concerns associated with injectable medicines across different regions and explore innovative solutions, like prefilled injectors, can combat transmittable diseases.
- Examine the issues of vaccine waste caused by multi-dose vials and identify potential solutions to reduce waste and improve access to essential vaccines.
- Discuss the crucial role of community health workers in bridging the gap between The Last Mile and successful vaccination campaigns.